Takeda-Nycomed Roiling Investment Suffering 40% Loss

Takeda-Nycomed Roiling Investment Suffering 40% Loss

JB Reed/Bloomberg

Generic versions of Takeda Pharmaceutical Co.’s best-selling drug Actos go on sale in 2012. Actos, first sold in the U.S. in 1999 and now the world’s top-selling diabetes medicine, accounted for 27 percent of Takeda’s sales last year.